×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 6: FDA Guidance Panel
Session Chair(s)
Marci C. Kiester, PharmD
Deputy Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States
Speaker(s)
Panelists
Julie Chronis, JD
FDA, United States
Regulatory Counsel, Office of Prescription Drug Promotion, CDER
Jean-Ah Kang, PharmD
FDA, United States
Special Assistant to the Director, Office of Prescription Drug Promotion, CDER
Distributing Scientific and Medical Publications on Unapproved New Uses--Recommended Practices
Robyn C. Tyler, JD, PharmD
FDA, United States
Lead Regulatory Counsel, Office of Prescription Drug Promotion, CDER
Distributing Scientific and Medical Publications on Risk Information for Approved Prescription Drugs and Biological Products - Recommended Practices
Kaylynn S. Yoon, JD, MHS
FDA, United States
Regulatory Counsel, CDER
Have an account?